US Stock MarketDetailed Quotes

SABS SAB Biotherapeutics

Watchlist
  • 1.5300
  • -0.0900-5.56%
Close Mar 26 16:00 ET
14.12MMarket Cap-0.24P/E (TTM)

About SAB Biotherapeutics Company

SAB Biotherapeutics, Inc. is a clinical-stage, biopharmaceutical company. It is engaged in advancing a new class of immunotherapies leveraging fully-human polyclonal antibodies. The firm produces human polyclonal immunotherapies and its versatile DiversitAb platform is applicable for unmet needs in human diseases. SAB Biotherapeutics was founded by Eddie J. Sullivan and Christine E. Hamilton in July 2014 and is headquartered in Miami Beach, FL.

Company Profile

SymbolSABS
Company NameSAB Biotherapeutics
Listing DateFeb 9, 2021
Founded2014
CEOMr. Samuel J. Reich
MarketNASDAQ
Employees57
Fiscal Year Ends12-31
Address777 West 41st Street,Suite 401
CityMiami Beach
ProvinceFlorida
CountryUnited States of America
Zip Code33140
Phone1-605-679-6980
Websitehttp://www.sab.bio

Company Executives

  • Name
  • Position
  • Salary
  • Samuel J. Reich
  • Chief Executive Officer and Director
  • 565.80K
  • Christoph Lawrence Bausch
  • Chief Operating Officer
  • 549.32K
  • Lucy To
  • Chief Financial Officer
  • --
  • Dr. Alexandra Kropotova, M.D.
  • Chief Medical Officer and Executive Vice President
  • 921.58K
  • Mark William Conley, C.P.A.
  • Vice President, Finance
  • --
  • Dr. Eddie J. Sullivan, PhD
  • Director and President
  • 202.60K
  • David Link, M.B.A.
  • Vice Chairman of the Board
  • 25.00K
  • Dr. Jay S. Skyler,M.D.,M.A.C.P.
  • Director
  • --
  • Andrew D. Moin
  • Independent Director
  • --
  • Christine Hamilton, M.B.A.
  • Independent Director
  • 25.00K
  • Admiral Scott Giberson, (Ret.)
  • Independent Director
  • 25.00K
  • Helen Katherine Ellias
  • Independent Director
  • --
  • Jeffrey G. Spragens
  • Independent Director
  • 25.00K
  • Erick J. Lucera, C.F.A.
  • Independent Director
  • 26.93K
  • Dr. William J. Polvino, M.D.
  • Independent Director
  • 25.00K

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
KB Home
KBH
59.110
Ecopetrol
EC
10.400
Petroleo Brasileiro SA Petrobras
PBR
14.330
4
Vale SA
VALE
10.130
5
Taylor Morrison Home
TMHC
60.890
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call
Earnings Season Underway
Earnings season is here. What to know?